¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) Á¦46Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦6Â÷ ±¹Á¦¾ÏÄÁÆÛ·±½º 1 : 2020-11-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) Á¦46Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦6Â÷ ±¹Á¦¾ÏÄÁÆÛ·±½º 1 : 2020-11-12
±³À°ÀÏÀÚ : 2020-11-12
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°(½Ç½Ã°£ È­»ó °­ÀÇ)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦46Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦6Â÷ ±¹Á¦¾ÏÄÁÆÛ·±½º 1      
ÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : ÀÌÈñ¿¬ 
¿¬¶ôó : 02-792-1486  
À̸ÞÀÏ : cancer4@kams.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈ­ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ,      
Âü¼®¿¹»óÀοø : 900¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 13 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 70,000¿ø      
ºñ°í 1.ȸ¿ø: 1) ±³¼ö, Àü¹®ÀÇ, ¼±ÀÓ¿¬±¸¿ø: 5¸¸¿ø / 2) Àü°øÀÇ, ¿¬±¸¿ø, ´ëÇпø»ý: 2¸¸¿ø / 3) ¾÷ü ¹× ¿¬±¸¼Ò: 5¸¸¿ø 2. ºñȸ¿ø: 1) ±³¼ö, Àü¹®ÀÇ, ¼±ÀÓ¿¬±¸¿ø: 7¸¸¿ø / 2) Àü°øÀÇ, ¿¬±¸¿ø, ´ëÇпø»ý: 3¸¸¿ø / 3) ¾÷ü ¹× ¿¬±¸¼Ò: 7¸¸¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 12ÀÏ Room A 09:40~10:20 Viral and cellular immunotherapeutics for cancer: From research to clinical care  Yuman Fong(City of Hope Medical Center) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room B 15:20~15:50 Is sphincter preservation the best way for rectal cancer?  °­¼º¹ü(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room B 15:50~16:20 Microsurgical treatment of lymphedema: Upper extremity and lower extremity  ±èÁÖÇü(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room B 16:20~16:50 Function preserving surgery for gastric cancer  ¾ÈÁö¿µ(¼º±Õ°üÀÇ´ë) 
Åä·Ð 11¿ù 12ÀÏ Room B 16:50~17:00 Q&A Discussion  () 
±³À°½Ã°£ 11¿ù 12ÀÏ Room B 13:30~13:55 Frontiers in theranostics  ¹Ú¿µÁÖ(¼­¿ï¼º¸ðº´¿ø) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room B 13:55~14:20 Spectroscopic tissue scanner for diagnosis of gastric cancer  À±È«¸¸(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room B 14:20~14:45 Integrative multi-omics analysis reveals consensus molecular subtypes reflecting distinct clinical phenotypes of hepatocellular carcinoma  À̼ºÈ¯(Â÷ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room B 14:45~15:10 Impact of wound healing on ovarian cancer progression and sensitivity to platinum based agent  ÀÌÀ¯¿µ(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room A 10:30~10:55 NTRK fusion-positive cancers and TRK inhibitor therapy  David S. Hong(MD Anderson Cancer Center) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room A 10:55~11:20 Exploring the best treatment options for BRAF-mutant  Hussein A. Tawbi(MD Anderson Cancer Center) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room A 11:20~11:45 Analysis of TMB and MSI Status and their treatment outcomes  ÇѼ¼¿ø(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room A 11:45~12:10 DNA damage pathways for cancer treatment  ¹Ú¿¬Èñ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room B 10:30~10:55 Oncogenic IRS4 activation in thymic epithelial tumors  ÁÖ¿µ¼®(KAIST) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room B 10:55~11:20 Cross-species oncogenic signatures of breast cancer in canine mammary tumors  ±è»ó¿ì(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room B 11:20~11:45 Recent update of breast cancer genomics  ÇÑ¿ø½Ä(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room B 11:45~12:10 Systems biology approach to overcome the therapeutic resistance to multikinase inhibitor  ¿øÀç°æ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room A 13:30~13:55 History and current status of AYA oncology  ÇÑÁ¤¿ì(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room A 13:55~14:20 Sarcomas in AYA  ÀÌÁؾÆ(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room A 14:20~14:45 Fertility preservation in female AYA with cancers  ÀÌÁ¤·Ä(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room A 14:45~15:10 Survivorship of AYA with cancers  Á¶ÁÖÈñ(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room A 15:20~15:45 The power of ONE: Immunology in the age of single cell genomics  Ido Amit(Weizmann Institute of Science) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room A 15:45~16:10 Utilizing machine intelligence for neoantigen identification  ÃÖÁ¤±Õ(KAIST) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room A 16:10~16:35 Machine learning-based immunogenomic analysis of TIME to predict immune directed therapy response in GC  Á¤ÀçÈ£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room A 16:35~17:00 Significance of tumor-specific and non-specific T cells in cancer immunotherapy  ½ÅÀÇö(KAIST) 
±³À°½Ã°£ 11¿ù 12ÀÏ Room A 08:30~09:30 Outstanding Abstract Session  ¹ÌÁ¤() 
±³À°½Ã°£ 11¿ù 12ÀÏ Room B 08:30~09:30 Satellite Symposium  ¹ÌÁ¤() 
±³À°½Ã°£ 11¿ù 12ÀÏ Room A 12:40~13:20 More TOMORROWs: Pembrolizumab will double the hope for mNSCLC patients in the 1st line  ±èÇý·Ã(¿¬¼¼ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) Á¦46Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦6Â÷ ±¹Á¦¾ÏÄÁÆÛ·±½º 1 : 2020-11-12""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ´ëÇÑ°ñ´ë»çÇÐȸ The 8th Seoul Symposium on Bone Health & Á¦32Â÷ Ãß°èÇмú´ëȸ : 2020-11-12
´ÙÀ½±Û 2020 ÀüºÏ°³¿ø³»°úÀÇ»çȸ À§´ëÀå³»½Ã°æÇÐȸ Çмú´ëȸ : 2020-11-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20853 ¼­¿ï »ï¼º¼­¿ïº´¿ø Á¤Çü¿Ü°ú Á¦21ȸ SMC Orthopedic Symposium 2024 : 2024-06-23 0 10 2024-05-27
20852 ÀÎõ Á¦3ȸ ÀÎÇϴ뺴¿ø ¿Ü°ú ½ÉÆ÷Áö¿ò : 2024-06-22 0 19 2024-05-27
20851 °æ±â (¿Â¶óÀÎ) Á¦7ȸ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¾îÁö·³Áõ¼¾ÅÍ ¿¬¼ö°­Á : 2024-06-22 0 34 2024-05-27
20850 ±¤ÁÖ 2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-22 0 17 2024-05-27
20849 ¼­¿ï ´ëÇÑÃé´ãµµÇÐȸ [¿Â¶óÀÎ] Pancreato-Biliary Summer School 2024 (PB-SS) : 2024-06-22 0 17 2024-05-27
20848 ¼­¿ï Á¦26Â÷ ¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú ¿¬¼ö°­Á : °áÇÙ°ú ºñ°áÇÙÇ×»ê±Õ ÆóÁúȯÀÇ ÃÖ½ÅÁö°ß : 2024-06-22 0 29 2024-05-27
20847 ¼­¿ï Á¦3ȸ Severance Orthopaedic Review(¼¼ºê¶õ½º ±Ù°ñ°Ý ¿¬¼ö°­ÁÂ) : 2024-06-22 0 11 2024-05-27
20846 ¼­¿ï (¿Â¶óÀÎ)2024³â ¼­´ë¹®±¸ÀÇ»çȸ ¿Â¶óÀÎÇмú´ëȸ : 2024-06-22 0 20 2024-05-27
20845 ¼­¿ï ´ëÇѳúÀüÁõÇÐȸ 29rd KOREAN EPILEPSY CONGRESS (2024 KEC) 2ÀÏÂ÷ : 2024-06-22 0 22 2024-05-27
20844 ´ë±¸ 2024³â Á¦ 23ȸ ´ëÇѵΰ³¾È¸é¼ºÇü¿Ü°úÇÐȸ Ãá°è½ÉÆ÷Áö¾ö : 2024-06-22 0 13 2024-05-27
20843 ¼­¿ï µ¿ÀÛ±¸ÀÇ»çȸ ÀÇÇÐ ¿¬¼ö±³À°(¸¸¼ºÁúȯ, Å»¸ð¿Í ÇǺΰü¸®, »ý¼ºÇü AI Æ®·»µå¿Í ÀÇ·á, ÀÇ·áºÐÀï) : 2024-06-22 0 18 2024-05-27
20842 ¼­¿ï (¿Â¶óÀÎ) °øȲ¹üºÒ¾ÈÀå¾Ö Ä¡·áÀÇ ½ÉÃþÀû Á¢±Ù : 2024-06-22 0 12 2024-05-27
20841 °æ±â 2024³â ´ëÇѳëÀκñ´¢ÀÇÇÐȸ Á¦7Â÷ Á¤±âÇмú´ëȸ : 2024-06-22 0 13 2024-05-27
20840 ¼­¿ï (¿Â¶óÀÎ) Á¦34Â÷ ´ëÇѼҾÆÀÓ»ó¸é¿ªÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-22 0 22 2024-05-27
20839 ´ë±¸ 2024 ´ë±¸±¤¿ª½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-22 0 31 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷